Dr. Carl Dieffenbach ( [ Ссылка ] ) is the Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health.
Dr. Dieffenbach has oversight of a global HIV/AIDS research portfolio of over one billion dollars and a staff of over 150 federal employees and is responsible for planning, implementing, managing, and evaluating programs in 1) fundamental basic laboratory research, 2) discovery and development of therapies and treatment strategies for HIV infection and its co-infections and/or complications through basic research and clinical trials, and 3) discovery and development of vaccines, topical microbicides, and other prevention strategies through basic research and clinical trials.
Over the years Dr. Dieffenbach played a key role in restructuring the DAIDS-supported clinical trials research networks and has actively fostered collaboration and partnerships with other federal agencies, international research organizations, professional societies, foundations, community advocacy groups, and industry.
Dr. Dieffenbach received his bachelor’s degree in biochemistry from the University of Maryland and his Ph.D. in biophysics from The Johns Hopkins University and completed his postdoctoral fellowship with the Uniformed Services University of the Health Sciences (USUHS) Department of Pathology.
#CarlDieffenbach #AIDS #HIV #NIAID #NationalInstitutesOfHealth #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research
